Drugging the Elusive KRAS
Kevan M. Shokat, PhD, shifted the paradigm of targeted cancer therapy by drugging an “undruggable” protein and paving the way for future advances.
Sex and Gender Minorities Face Disparities in Breast Cancer Care
Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.
by Jon KelveyDeconstructing Peripheral Neuropathy and Chemo Brain
Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. LandsmannAACR Annual Meeting 2023
Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.More Prostate Cancer Patients Choose Surveillance
Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose